Redx Pharma plc

Royaume‑Uni

Commandez votre montre hebdomadaire Redx Pharma plc
Quantité totale PI 59
Rang # Quantité totale PI 23 608
Note d'activité PI 2,3/5.0    27
Rang # Activité PI 28 822
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

15 0
7 0
36 0
1
 
Dernier brevet 2024 - Phenyl- and pyridopyrazole deriv...
Premier brevet 2004 - Process and intermediate compoun...
Dernière marque 2011 - Redx
Première marque 2011 - Redx

Industrie (Classification de Nice)

Derniers inventions, produits et services

2023 Invention Compounds. This invention relates to compounds that may be useful for inhibiting RAS proteins. Mo...
Invention Solid forms of a rock inhibitor. This invention relates to a single enantiomer and crystalline fo...
Invention Pyrido-pyrazoles as inhibitors of ddr's for the treatment of fibrotic disorders and cancer. This ...
Invention N-pyridinyl acetamide derivatives as inhibitors of the wnt signaling pathway. This invention rela...
Invention Modulators of rho-associated protein kinase (rock). This invention relates to novel compounds and...
2022 Invention Ddr1 and ddr2 inhibitors for the treatement of cancer and fibrotic diseases. This invention relat...
Invention N-pyridinyl acetamide derivatives as wnt signalling pathway inhibitors. Disclosed are compounds ...
Invention Phenyl- and pyridopyrazole derivatives as inhibitors of ddr1. This invention relates to novel co...
Invention Phenyl- and pyridopyrazole derivatives as inhibitors of ddr1. This invention relates to novel com...
Invention Quinazoline derivatives useful as ras inhibitors. This invention relates to compounds that may b...
Invention Quinazoline derivatives useful as ras inhibitiors. This invention relates to compounds that may b...
Invention Pyrido[4,3-d]pyrimidine compounds capable of inhibiting kras mutant proteins. This invention rel...
Invention Pyrido[4,3-d]pyrimidine compounds capable of inhibiting kras mutant proteins. This invention rela...
Invention Pharmaceutical formulation. This invention relates to pharmaceutical formulations and a method o...
Invention Pharmaceutical formulation. This invention relates to pharmaceutical formulations and a method of...
2020 Invention N-pyridinyl acetamide derivatives as wnt signalling pathway inhibitors. Disclosed are compounds u...
2019 Invention Heterocyclylamino-substituted triazoles as modulators of rho-associated protein kinase. This inve...
2018 Invention N-pyridinyl acetamide derivatives as inhibitors of the wnt signaling pathway. Disclosed are compo...
2017 Invention Pyridine derivatives as soft rock inhibitors. The present invention relates to new kinase inhibit...
Invention Antibacterial compounds. This invention relates to antibacterial drug compounds containing a bic...
Invention Heterocyclic compounds, in particular 2-oxo-4,4,5,5,6,6,7,7-octahydrobenzoxazole derivatives, and...
Invention Antibacterial compounds. This invention relates to antibacterial drug compounds containing a bicy...
2016 Invention Resistant bacteria. The present invention relates to bacteria expressing mutated forms of GrlB pr...
Invention Antibacterial compounds and new uses thereof. This invention relates to a series of compounds of ...
Invention Antibacterial compounds. This invention relates to antibacterial and anti-mycobacterial drug comp...
Invention Antibacterial compounds. This invention relates to antibacterial and antimycobacterial drug compo...
Invention Antiviral compounds. This invention relates to a series of tricyclic compounds comprising a pteri...
Invention Antibacterial compounds. The present invention relates to antibacterial drug compounds containing...
2015 Invention Compounds with activity against bacteria and mycobacteria. This invention relates toantibacterial...
Invention 6,7-heterocyclic fused 5h-pyrrolo[1,2-c]imidazole derivatives and their use as indoleamine 2,3-di...
Invention N-pyridinyl acetamide derivatives as inhibitors of the wnt signalling pathway. This invention rel...
Invention N-pyridinyl acetamide derivatives as wnt signalling pathway inhibitors. This invention relates to...
Invention Compounds useful as csf1 modulators. This invention relates to novel compounds and to pharmaceuti...
Invention 4h-imidazo[1,5-a]indole derivatives and their use as indoleamine 2,3-dioxygenase (ido) and/or try...
Invention Fused bicyclic (hetero)aromatic compounds useful for the treatment of cancers. This invention rel...
Invention Antibacterial compounds. This invention relates to antibacterial drug compounds containing a tric...
Invention Antibiotic-resistant bacteria and their uses. Provided are novel bacteria that have increased ant...
Invention Pyrazolopyrimidine derivatives useful as inhibitors of bruton's tyrosine kinase. This invention r...
Invention Antibacterial compounds. The invention relates to antibacterial and anti-mycobacterial drug compo...
Invention Pyrazolo-pyrimidines as inhibitors of btk. This invention relates to novel compounds. The compoun...
2014 Invention Heterocyclic compounds as hedgehog signaling pathway inhibitors. This invention relates to novel ...
2011 P/S Pharmaceutical preparations.